Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Mov Disord Clin Pract. 2017 Dec 10;5(2):149–155. doi: 10.1002/mdc3.12573

Figure 1.

Figure 1

(A) Distribution of different lysosomal storage diseases (LSD) in this cohort of 76 patients with a clinical, genetic and/or biochemical diagnosis of a LSD. (B) Summary of 18 LSD patients who presented with at least one of the predefined movement disorders (parkinsonism, dystonia, ataxia, tremor, chorea, myoclonus, ballism, restless leg syndrome). (C) Distribution of 36 movement disorders in these 18 patients. Abbreviations: AG (aspartylglycosaminuria), CLN (ceroid lipofuscinosis), MPS (mucopolysaccharidosis).